MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells
- PMID: 24014244
- PMCID: PMC3811175
- DOI: 10.1182/blood-2012-12-475087
MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells
Abstract
During microbial infections, plasmacytoid dendritic cells (pDCs) are a main source of type I interferons α/β (IFN-α/-β). Nucleic acids from microbes are sensed by Toll-like receptors 7/9 (TLR7/9), which are selectively expressed in pDCs. Activated pDCs also produce proinflammatory cytokines and upregulate costimulatory molecules. Together, this equips pDCs with the ability to prime T, B, and NK cells and conventional DCs, thereby initiating adaptive immune responses. To avoid deleterious effects to the host, tight regulation of pDC activation is required. Despite data linking aberrant activation of pDCs with autoimmune diseases, little is known about mechanisms controlling pDC activation. Here, we investigated the role of microRNA-146a (miR-146a) in TLR pathway regulation in human pDCs. MiR-146a expression was induced upon TLR7/9 signaling. Furthermore, ectopic miR-146a expression effectively impaired TLR-mediated signaling in pDCs as TLR-induced nuclear factor-κB activation was reduced. This consequently diminished the production of proinflammatory cytokines and reduced pDC survival. Moreover, miR-146a-expressing pDCs had decreased ability to induce CD4(+) T-cell proliferation likely due to reduced expression levels of major histocompatibility complex class II and costimulatory molecules. Our data unravel the crucial immunomodulatory role of miR-146a in pDCs and may add to our understanding of aberrant responses in autoimmune diseases.
Figures





Similar articles
-
HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells.J Immunol. 2012 Dec 1;189(11):5257-65. doi: 10.4049/jimmunol.1201905. Epub 2012 Oct 24. J Immunol. 2012. PMID: 23100517 Free PMC article.
-
Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.Eur J Immunol. 2014 Apr;44(4):1130-6. doi: 10.1002/eji.201344030. Epub 2014 Jan 20. Eur J Immunol. 2014. PMID: 24375473
-
Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11chiCD11b+ Dendritic Cells in NZB/W F1 Mice.Int J Mol Sci. 2019 Sep 19;20(18):4639. doi: 10.3390/ijms20184639. Int J Mol Sci. 2019. PMID: 31546763 Free PMC article.
-
Regulation of TLR7/9 signaling in plasmacytoid dendritic cells.Protein Cell. 2013 Jan;4(1):40-52. doi: 10.1007/s13238-012-2104-8. Epub 2012 Nov 7. Protein Cell. 2013. PMID: 23132256 Free PMC article. Review.
-
Plasmacytoid dendritic cells in antiviral immunity and autoimmunity.Sci China Life Sci. 2010 Feb;53(2):172-82. doi: 10.1007/s11427-010-0045-0. Epub 2010 Mar 7. Sci China Life Sci. 2010. PMID: 20596824 Free PMC article. Review.
Cited by
-
Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.Int J Mol Sci. 2021 Apr 18;22(8):4190. doi: 10.3390/ijms22084190. Int J Mol Sci. 2021. PMID: 33919546 Free PMC article. Review.
-
IFN-α-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment.J Interferon Cytokine Res. 2015 Sep;35(9):698-709. doi: 10.1089/jir.2014.0211. Epub 2015 Jun 19. J Interferon Cytokine Res. 2015. PMID: 26090579 Free PMC article.
-
Differentially Tolerized Mouse Antigen Presenting Cells Share a Common miRNA Signature Including Enhanced mmu-miR-223-3p Expression Which Is Sufficient to Imprint a Protolerogenic State.Front Pharmacol. 2018 Aug 17;9:915. doi: 10.3389/fphar.2018.00915. eCollection 2018. Front Pharmacol. 2018. PMID: 30174602 Free PMC article.
-
Dysregulated co-stimulatory molecule expression in a Sjögren's syndrome mouse model with potential implications by microRNA-146a.Mol Immunol. 2015 Dec;68(2 Pt C):606-16. doi: 10.1016/j.molimm.2015.09.027. Epub 2015 Oct 23. Mol Immunol. 2015. PMID: 26505653 Free PMC article.
-
Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis.Inflammation. 2017 Aug;40(4):1460-1473. doi: 10.1007/s10753-017-0589-2. Inflammation. 2017. PMID: 28523463
References
-
- Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005;23:275–306. - PubMed
-
- Lande R, Gilliet M. Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann N Y Acad Sci. 2010;1183:89–103. - PubMed
-
- Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008;8(8):594–606. - PubMed
-
- Hayden MS, West AP, Ghosh S. NF-kappaB and the immune response. Oncogene. 2006;25(51):6758–6780. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials